1. Feldman JM, Blalock JA, Zern RT, Shelburne JD, Gaede JT, Farrell RE, et al. Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol. 1979. 72:175–185.
2. Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, et al. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery. 1986. 100:1154–1162.
3. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab. 2005. 90:2068–2075.
4. Dubois LA, Gray DK. Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg. 2005. 29:909–913.
5. Tam V, Ng KF, Fung LM, Wong YY, Chan MH, Lam CW, et al. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem. 2005. 42(Pt 1):73–77.
6. Awada SH, Grisham A, Woods SE. Large dopamine-secreting pheochromocytoma: case report. South Med J. 2003. 96:914–917.
7. Yasunari K, Kohno M, Yoshikawa J. A dopamine-secreting pheochromocytoma. Am J Med. 1999. 106:599–600.
8. Foo SH, Chan SP, Ananda V, Rajasingam V. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management. Singapore Med J. 2010. 51:e89–e93.
9. Sata N, Shiozawa M, Suzuki A, Kurihara K, Ohki J, Nagai H. Retroperitoneal hand-assisted laparoscopic surgery for endoscopic adrenalectomy. Surg Endosc. 2006. 20:830–833.
10. Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest. 1992. 15:631–642.